4.035
1.13%
0.045
시간 외 거래:
4.04
0.005
+0.12%
Fennec Pharmaceuticals Inc (FENC) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
154.94%
25.38
|
9.954 | 6.296 | -12.51 | 1.582 |
Operating Expenses
|
7.05%
11.63
|
10.87 | 7.201 | -7.843 | 6.852 |
Benefits Costs and Expenses |
67.35%
12.54
|
38.41 | - | -7.065 | 7.634 |
Costs And Expenses |
67.35%
12.54
|
38.41 | - | -7.843 | 6.852 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
855.94%
13.74
|
-1.818 | -1.017 | -4.666 | -5.27 |
Net Interest Income/Expense |
71.30%
0.197
|
0.115 | 0.102 | - | - |
Nonoperating Income/Loss |
4.86%
-0.906
|
-0.864 | -0.85 | -0.778 | -0.782 |
Income/Loss From Continuing Operations Before Tax |
145.11%
12.84
|
-28.46 | 6.296 | -5.444 | -6.052 |
Income/Loss From Continuing Operations After Tax |
145.11%
12.84
|
-28.46 | 0.917 | -5.444 | -6.052 |
Net Income/Loss
|
145.11%
12.84
|
-28.46 | 0.917 | -5.444 | -6.052 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
52,929%
27.05
|
0.051 | 26.60 | 26.46 | 26.56 |
Diluted Average Shares |
60,863%
31.09
|
0.051 | 26.60 | 26.46 | 26.56 |
Basic Earnings Per Share |
415.38%
0.41
|
-0.13 | -0.03 | -0.21 | -0.23 |
Diluted Earnings Per Share |
415.38%
0.41
|
-0.13 | -0.03 | -0.21 | -0.23 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):